SEC Form 4 · accession 0001209191-17-022993
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Joseph Nelson
Officer — SVP & Chief Financial Officer
Period of report
Mar 27, 2017
Accepted (ET)
Mar 27, 2017 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.28 | Mar 27, 2017 | A | 600,000 | A | — | Mar 27, 2027 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1As to 400,000 of the stock options, one-fourth vest on the one-year anniversary of grant, and the remaining three-fourths vest ratably on a monthly basis over a three-year period, and as to 200,000 of the stock options, based upon certain performance criteria as established by the Compensation Committee of the Board of Directors, in all cases subject to Reporting Person's continued service through the applicable vesting dates.